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ABSTRACT
CRASSOUS, B., H. RICHARD-BULTEAU, L. DELDICQUE, B. SERRURIER, M. PASDELOUP, M. FRANCAUX, X. BIGARD,
and N. KOULMANN. Lack of Effects of Creatine on the Regeneration of Soleus Muscle after Injury in Rats. Med. Sci. Sports Exerc.,
Vol. 41, No. 9, pp. 1761–1769, 2009. Purpose: Creatine (Cr) supplementation may improve muscle functional capacity in patients with
neuromuscular diseases, disuse atrophy, or muscular dystrophies. Activation of myogenic satellite cells has been reported to be
enhanced by Cr both in vitro and in vivo. Therefore, we hypothesized that Cr supplementation may improve the early steps of
regeneration after muscle injury and may accelerate the recovery of both muscle mass and phenotype. Methods: Degeneration of left
soleus muscle was induced by notexin injection in rats supplemented or not with Cr. The mass of regenerated muscles was compared
with contralateral intact muscles at days 1, 3, 7, 14, 21, 28, 35, and 42 after injury. We also studied protein levels of the proliferator cell
nuclear antigen (PCNA) as a marker of cell proliferation, expression of myogenic regulatory factors (MRF) as a marker of
differentiation, and the myosin heavy chain (MHC) profile and activities of citrate synthase (CS) and lactate dehydrogenase (LDH)
isozymes as markers of muscle phenotype maturation. Results: Cr supplementation accelerated the recovery of muscle Cr content
during the regeneration phase. Although there were no other differences between Cr-treated and nontreated rats, we observed that 1)
regenerated muscle mass remained lower than that in intact muscle mass 42 d after injury, 2) PCNA and MRF expression strongly
increased in regenerated muscles, 3) the MHC profile of regenerated muscles was recovered 28 d after injury, and 4) CS activity was
fully recovered from day 14, whereas the specific H isozyme of lactate dehydrogenase activity remained lower than that in intact
muscles until 42 d. Conclusions: In contrast with results from in vitro studies, Cr supplementation had no effects in vivo on the time
course of recovery of rat skeletal muscle mass and phenotype after notexin-induced injury. Key Words:MUSCLE INJURY, MUSCLE
MASS, MUSCLE PHENOTYPE, MRF, MHC, OXIDATIVE ENZYMES
U
naccustomed or high-intensity exercise, especially
when it involves eccentric contractions, can induce
skeletal muscle damage and temporary impairment
of muscle function (3,19). Exercise-induced muscle damage
is characterized mainly by disruption of sarcomeres and
sarcolemma, leading to protein leakage from myofibers, as
illustrated by elevated levels of myoglobin and creatine (Cr)
phosphokinase activity in plasma (4,29). Adult skeletal
muscle has the remarkable capacity to regenerate after
injury, mainly because of the satellite cells that represent a
population of adult myoblasts that remain normally quies-
cent (24). Once activated after muscle injury, satellite cells
rapidly proliferate, fuse, and differentiate to form new
myofibers or to repair the damaged ones (2).
More than 30 yr ago, Ingwall et al. (20,21) reported that
Cr stimulated incorporation of labeled amino acids into
myosin heavy chain (MHC), the major myofibrillar protein,
and stimulated muscle-specific protein synthesis in chicken
myotubes in culture. However, in contrast to their reports, it
was further found that Cr had no effect on myosin synthe-
sis or on total protein synthesis (15). More recently, it
was shown that the fusion of myogenic C2C12 (11) and
satellite (35) cells is largely enhanced while creatine (Cr)
is added to the culture medium during the differentiation
phase. This was at least partly mediated by overexpres-
sion of insulin-like growth factor 1 and myogenic reg-
ulatory factors (MRF) (23). MRF are members of a family
of basic helix–loop–helix proteins that act as transcription
activators and regulate the transcription of some muscle-
specific genes (31).
Creatine monohydrate (Cr) is one of the most com-
monly used supplements taken by athletes, recreational
exercisers, and the elderly and children of both sexes. Cr
loading has been widely studied because of its potential
ergogenic effects in sports performance (for review, see
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[5]). In addition, recent studies have shown that Cr can
enhance muscle functional capacity in patients with
neuromuscular diseases, disuse atrophy, or muscular dys-
trophies (18,22,34). When combined with resistance train-
ing sessions, Cr activates human satellite cells at a higher
level than resistance training alone (25) and accelerates
muscle recovery after an immobilization period (18). These
observations provide rationality for the use of Cr in patients
in rehabilitation and could explain the beneficial effects of
Cr in patients experiencing neuromuscular disease, disuse
atrophy, and muscle dystrophies (33).
To date, the putative beneficial effects of Cr supplemen-
tation on recovery of muscle mass and/or phenotype after
muscle injury remain to be examined in vivo. The current
experiment was designed to test the hypothesis that Cr
supplementation ingested during the regenerative period
after extensive muscle injury could favor the recovery of
both muscle mass and adult muscle phenotype, including
recovery of protein involved in contractile function and
metabolism.
MATERIALS AND METHODS
Animals. Female Wistar rats initially weighing 180–
200 g were purchased from Charles River Laboratories
(L’Arbresle, France). Animals were housed two per cage in a
thermoneutral environment (22 T 2-C) on a 12:12 h photo-
period and were provided with powder food and water ad
libitum. Rat care and all experimental procedures used were
in accordance with the policy statement of the American
College of Sports Medicine on research with experimental
animals. The study was approved by Ethical Committee for
Animal experiments at the Centre de Recherches du Service
de Sante´ des Arme´es de Grenoble, France.
Experimental design. Three days before myotoxic-
induced degeneration of soleus (SOL) muscle, rats were
randomly assigned to one of two groups, either supple-
mented (Cr) or not (N) with Cr (anhydrous Creatine;
Sigma Aldrich, Saint Quentin Fallavier, France) adminis-
tered both in powder food (4.7%) and drinking water
(1.4%). At day 0 of the experiment (D0), degeneration of
the left SOL muscle was induced by notexin injection. As
previously reported, the noninfiltrated right SOL muscle
served as intact control muscle (14,27). Eight animals of
each group were then anesthetized for tissue sampling
and killed 1, 3, 7, 14, 21, 28, 35, and 42 d after initial
muscle injury (D1, D3, D7, D14, D21, D28, D35, D42,
respectively).
Notexin injection. Rats were anesthetized with so-
dium pentobarbital (60 mgIkgj1) and left SOL muscle
degeneration was induced by notexin injection (0.2 mL,
10 KgImLj1) isolated from snake venom (Notechis
scutatus, Latoxan, Valence, France) directly into the belly
of the muscle surgically exposed as previously described
(14). Because the blank surgery did not induce any specific
alteration in muscle tissue, no surgical procedure was done
on the right SOL, which served as an intact control. The
effects of Cr supplementation were then studied in regen-
erating SOL muscle (Reg), in comparison with contralateral
intact noninjured muscles (Int).
Tissue processing. Animals were anesthetized with
sodium pentobarbital (90 mgIkgj1) administered intra-
peritoneally. Regenerated (i.e., left) and intact (i.e., right)
SOL muscles were excised, cleaned of adipose and con-
nective tissues, and weighed. Muscles were immediately
frozen in liquid nitrogen. All samples were stored at j80-C
until analyses were performed.
Histomorphometric analyses. Serial transverse
sections (12 Km thick) were cut from the midbelly portion
of SOL in a cryostat microtome maintained at j20-C and
stained with hematein, eosin, and safran (HES) to visualize
nucleus, cytoplasm, and connective tissue at each time of
recovery. To determine the total number of myofibers,
photographs of the entire muscle were taken at low
magnification. Moreover, 20 to 30 photographs at high
magnification, covering the entire muscle section, were
used to determine the cross-sectional area of at least 1000
fibers in each muscle sample at D42, for both Int and Reg
muscles. Analyses were performed with a light microscope
computerized image analysis system (Lucia 5; Laboratory
Imaging, Prague, Czech Republic).
Analysis of muscle Cr content. Approximately 10–
15 mg of muscle was used for spectrophotometric determi-
nation of free and total Cr (TCr = Cr phosphate + free Cr).
Muscle was extracted in 0.25 N HClO4 and neutralized with
1 N KOH. To hydrolyze creatine phosphate (PCr), 2 N HCl
was added to the supernatant, which was then heated for
15 min at 60-C. The reaction was stopped on ice, and the
supernatant was neutralized with 2 N NaOH. TCr was
immediately determined enzymatically using a spectropho-
tometric method, as previously described (16) (Creatinine
PAP; Boehringer Mannheim, Germany, from which the
creatininase was omitted). Free Cr was determined by the
same method omitting the step of PCr hydrolysis. PCr
content was then calculated as the difference between TCr
content and free Cr.
Analysis of the distribution of MHC isoforms.
Muscles were subjected to the analysis of MHC isoforms
as described previously (32). Myosin was extracted from
small sections of muscles in seven volumes of buffer solution
(0.3 M NaCl, 0.1 M NaH2PO4, 0.05 M Na2HPO4, 0.01 M
Na4P2O7, 1 mM MgC12I6H2O, 10 mM EDTA, 1.4 mM 2-A-
mercaptoethanol, pH = 6.5). Electrophoresis was performed
using a Mini Protean II system (Bio-Rad, Marne-la-Coquette,
France) with 8% and 4% acrylamide-bis (50:1) separating
and stacking gels, respectively, containing 0.4% sodium
dodecyl sulfate (SDS). Myofibril samples were denatured
with the SDS incubation medium, according to the method
of Laemmli. Gels were run at constant voltage (72 V) for
31 h and then silver-stained (1). The MHC protein isoform
bands were scanned and quantified using a densitometer GS
800 driven by Quantify One 4.6.1 (Bio-Rad).
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Protein isolation and immunoblot analyses. A
range of 10 to 20 mg of muscle was lysed with the appropriate
buffer, and homogenates were all centrifuged at 15,000g for
15 min at 4-C. Protein content was determined using the
bicinchronic acid method (Roche/Hitachi 912 Instrument;
Roche Diagnostic, Mannheim, Germany). Equal amounts of
muscle protein (1, 12, 50, and 75 Kg for MHC, proliferator
cell nuclear antigen (PCNA), myogenin, and MyoD, respec-
tively) were separated on SDS–polyacrylamide gel electro-
phoresis (PAGE) and transferred onto nitrocellulose
membranes (Hybond C-extra; Amersham Pharmacia Bio-
tech, Orsay, France), which means that lane loading was
normalized for total muscle protein content. A standardized
amount of protein prepared from intact SOL was also applied
on each gel to serve as an internal standard for comparison
across blots. Membranes were incubated overnight with the
appropriate target antibody and then 2 h with the cor-
responding horseradish peroxidase-conjugated antibody.
Washed blots were subjected to the ECL Western blotting
detection reagent kit (ECL; Amersham Pharmacia Biotech)
and then exposed to x-ray film (Hyperfilm ECL; Amersham
Pharmacia Biotech). The relative protein expression was
determined by the ratio of sample band intensity to internal
standard band intensity by densitometry, using the densi-
tometer system described previously.
Immunoblot antibodies. The following antibodies
were used: mouse monoclonal antibodies against slow type
IA MHC (1:200 dilution, NCL-MHCS; Novocastra, New-
castle upon Tyne, United Kingdom), myogenin (1:500,
sc-12732 [F5D], Santa Cruz Biotechnology, Heidelberg,
Germany), PCNA (1:500, Ab-1 Clone PC10; NeoMarkers
Interchim, Montlu0on, France), and MyoD (1:500, no.
554130 clone MoAb 5.8A; BD Pharmingen, BD Bio-
sciences, Pont de Claix, France). Incubation with horse-
radish peroxidase-conjugated goat antimouse IgG antibody
was used as secondary antibody (1:4000, 1:2000, 1:2500,
and 1:5000 dilutions for MHC, myogenin, PCNA, and
MyoD, respectively, sc-2005; Santa Cruz Biotechnology).
Activities of metabolic enzymes. Frozen tissue
samples were weighed and placed into an ice-cold homog-
enization buffer (30 mg wet massImLj1) containing: 5 mM
HEPES (pH 8.7), 1 mM EGTA, 1 mM dithiothreitol, 5 mM
MgCl2, and 0.1% Triton. Samples were homogenized using
a microglass hand homogenizer and were incubated for 60
min at 0-C to ensure complete enzyme extraction. Citrate
synthase (CS) and lactate dehydrogenase (LDH) activities
were measured at 30-C (pH 7.5) using coupled enzyme
systems as previously described (6). The LDH isoenzyme
profile was determined using agarose gel electrophoresis
(Sigma LDH Reagent Kit; Sigma) at 200 V for 90 min
followed by image analysis using the densitometer system.
Statistical analysis. All data are presented as means T
SEM. Data were analyzed using a three-way ANOVA to
determine the main statistical effects of time, injury and Cr
supplementation, and interactions between those factors.
When appropriate, differences between groups were tested
with a Newman–Keuls post hoc test, especially to compare
values measured during muscle regeneration with those
observed in contralateral noninjured muscles. Statistical
significance was accepted at P G 0.05. When no effect of
time was observed within intact muscles, results were
reported with values of intact muscles pooled.
RESULTS
Body and Muscle Mass
The mean body mass of rats was similar in the two
groups when muscle degeneration was induced by notexin
injection. There was a global effect of time (P G 0.001) on
the body mass of animals. Consistent with the expected
growth rate of animals, the body mass increased regularly
from D1 to D42 both in Cr-treated and nontreated rats.
Mass of both intact and regenerated muscles of Cr- and
nontreated animals are reported Table 1. The three-way
ANOVA revealed neither main effect of Cr supplementa-
tion nor interaction between Cr and time or between Cr
and injury. By contrast, there were main effects of time
(P G 0.001) and injury (P G 0.001), with a strong interaction
between those factors (P G 0.001) indicating that only
regenerated muscle mass varied along time without differ-
ences in intact muscle mass. As a consequence, the regen-
erated muscle mass was normalized and expressed as the
ratio of the mass of regenerated muscle to the mass of
contralateral intact muscle (Fig. 1). Relative muscle mass
was first increased at D1 after notexin-induced injury (P G
0.001), then markedly decreased until D7 when regenerated
muscle mass represented only 66% and 74% of intact
muscle mass (P G 0.001) for Cr-treated and nontreated
rats, respectively. Relative muscle mass then only slowly
increased from D7 to D42. However, regenerated muscles
did not fully recover mass values similar to intact muscles,
even 42 d after initial injury (12% and 17% less than
intact muscles of Cr-treated and nontreated rats, respec-
tively, P G 0.01).
Histological and Morphological Aspects of
Regenerated Muscles
Histological aspects of intact muscles were similar in
nontreated (Fig. 2A) and Cr-treated animals (Fig. 2B). At
D7 of regeneration, all necrotic fibers appeared to have
TABLE 1. Mass of SOL muscles (mg).
Int Int-Cr Reg Reg-Cr
D1 106 T 5 103 T 4 175 T 13*** 167 T 10***
D3 105 T 3 107 T 7 112 T 15† 113 T 10†
D7 112 T 3 112 T 5 85 T 7† 73 T 4**†
D14 113 T 5 102 T 4 80 T 5* 72 T 3*
D21 110 T 4 112 T 3 83 T 5 90 T 6
D28 114 T 6 114 T 3 90 T 4 96 T 4
D35 110 T 3 112 T 3 96 T 4 101 T 5
D42 114 T 4 116 T 4 94 T 4 97 T 6
ANOVA global effects: time, P G 0.001; injury, P G 0.001; time  injury interaction,
P G 0.001.
* P G 0.05, **P G 0.01, ***P G 0.001, different from corresponding intact muscle.
† P G 0.001, different from previous time.
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been replaced by regenerated myofibers (Fig. 2C and D).
The size of these fibers was still smaller than the noninjured
fibers, and most of the regenerating fibers showed central
nuclei. By 21 d after injury, the regeneration process was in
progress and numerous small diameter fibers were present
(Fig. 2E and F). Extracellular spaces were large both in
nontreated and Cr-treated animals, likely related to fibrosis
as highlighted by safran staining. By 42 d after toxin injec-
tion, myofibers remained irregular with variable diameters
and large space between fibers (Fig. 2G and H). The histo-
logical aspects of regenerated muscles were similar in non-
treated and Cr-treated rats, all along the recovery period.
The mean fiber cross-sectional area and the number of fibers
per cross-section of muscles at D42 are given Table 2. The
two-way ANOVA revealed a strong effect of injury
(P G 0.001) and no effect of Cr supplementation for both
variables. The mean fiber cross-sectional area was strongly
decreased (P G 0.001) and the number of fibers increased
(P G 0.001) in regenerated muscles compared with intact ones.
TCr and PCr Contents
The three-way ANOVA revealed main effects of time
(P G 0.001), injury (P G 0.001), and Cr supplementation
(P G 0.001 and P G 0.05 for TCr and PCr, respectively),
with a strong interaction between injury and time for TCr
only (P G 0.001). The duration of Cr treatment had no effect
on TCr and PCr contents within intact muscles, so we de-
cided to present graphically the results of all intact muscles
pooled (Fig. 3). Cr supplementation significantly increased
TCr content of intact muscles (+19 T 8%, P G 0.01) and
only tended to increase the PCr content (+11 T 10%, NS).
By contrast, TCr and PCr contents were strongly decreased
early after initial injury (global effect of injury, P G 0.001)
while they progressively recovered during muscle regen-
eration (global effect of time, P G 0.001). Recovery was
enhanced in Cr-treated rats (global effect of Cr supple-
mentation, P G 0.001 and P G 0.05 for TCr and PCr,
respectively). At D35, TCr and PCr contents of Cr-treated
rats were similar in regenerated and intact muscles, whereas
they remained lower in regenerated than in intact muscles
of nontreated animals (P G 0.05).
Proliferative and Differentiation Markers of the
Regenerative Process
PCNA protein expression is a marker of cell prolifera-
tion. Whereas PCNA protein expression was very low in
intact muscles, it was markedly increased in regenerating
muscles (global effect of injury, P G 0.001) with the highest
levels at D3 and then progressively returned to basal values
at D14 (global effect of time of recovery, P G 0.001;
Fig. 4A). There were no differences between Cr-treated and
nontreated animals. Because its expression did not vary
along time within intact muscles, the results of intact
muscles of either nontreated or Cr-treated rats were pooled
for graphical representation (Fig. 4A).
FIGURE 1—Relative regenerated SOL muscle mass. The regenerated
muscle mass was expressed as the ratio of the absolute mass of
regenerated muscle to the contralateral intact muscle mass. Data are
presented as mean T SEM. The dotted line represents the full recovery
of muscle mass compared with contralateral intact muscle. *Different
from intact group. †Different from the previous time for the same
group.
FIGURE 2—Cross-sections of SOL muscle stained with HES. Serial
transverse sections (12 Km thick) were cut from the midbelly portion
of SOL in a cryostat microtome maintained at –20-C and stained with
HES to visualize nucleus, cytoplasm, and adipose tissue, respectively.
Transversal sections of intact SOL muscle at D21 [nontreated (A) or
Cr-treated (B) rats], of regenerating muscle at D7 [nontreated (C ) or
Cr-treated (D) rats], D21 [nontreated (E ) or Cr-treated (F )], and D42
[nontreated (G ) or Cr-treated (H ) rats]. Scale bar, 100 Km.
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MyoD expression is commonly used as a reliable marker
of satellite cell activation. MyoD protein levels markedly
increased in regenerated muscles (global effect of injury,
P G 0.001) with a peak as soon as D1 after muscle injury
(Fig. 4B). Then MyoD protein expression slowly decreased,
with higher levels in regenerated than those in intact
muscles until D3 and D7, for nontreated and Cr-treated
rats, respectively (P G 0.05). There was no significant effect
of Cr supplementation on MyoD protein expression during
the early step of muscle regeneration. In intact muscles,
MyoD protein expression was similar whatever the time of
observation, so that we have pooled the results of all intact
muscles of either nontreated or Cr-treated rats for graphical
representation (Fig. 4B).
Myogenin is a protein known to be expressed during the
terminal differentiation program. As expected, myogenin
protein levels were higher in regenerated than that in intact
muscles (global effect of injury, P G 0.001). There was a
marked effect of time (global effect, P G 0.001), with an
interaction with muscle injury (P G 0.001). As a result, the
increased myogenin expression in regenerated muscles was
only observed at D3 (P G 0.001, in comparison with intact
muscles). Thereafter, myogenin protein levels decreased to
values observed in intact muscles as soon as D7. Moreover,
there was no effect of Cr supplementation on myogenin
protein levels, all along the regenerative process. Because
its expression did not vary along time within intact
muscles, we decided to pool the results of intact muscles
of either nontreated or Cr-treated rats for graphical rep-
resentation (Fig. 4C).
Evaluation of the Maturation Step of the
Regenerative Process
MHC protein expression. Although MHC is one of
the most abundant proteins in skeletal muscle, MHC-IA
represents at least 90% of total MHC within adult intact
SOL muscle of rats. The time course of expression of this
TABLE 2. Morphological characteristics of SOL muscle at D42.
Int Int-Cr Reg Reg-Cr
Fiber cross-sectional
area (Km2)
2545 T 131 2649 T 114 1471 T 50* 1524 T 89*
Number of fibers per
muscle cross-section
1806 T 116 1858 T 83 2677 T 536* 2542 T 349*
* Different from intact group, P G 0.001.
FIGURE 3—TCr (A) and phosphocreatine (B) contents within whole
muscle tissue. TCr was determined enzymatically using a spectropho-
tometric method. PCr was calculated as the difference between TCr
and free Cr, the latter was measured before the hydrolysis of PCr.
Data are presented as mean T SEM. *Different from intact group.
†Different from the previous time for the same experimental group.
#Different from nontreated animals.
FIGURE 4—PCNA (A), MyoD (B), and myogenin (C) protein
expression. Protein expression was measured by Western blotting.
The relative protein expression was determined by the ratio of the
sample value to an internal standard control. Values are means T
SEM. *Different from intact group. †Different from the previous time
for the same experimental group.
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specific isoform during regeneration after injury is viewed
as a marker of contractile phenotype maturation.
There was a global effect of injury (P G 0.001) and time
(P G 0.001) on the distribution of MHC isoforms, with a
strong interaction between these factors (P G 0.001) for all
adult (MHC-I, MHC-IIA, MHC-IIX, MHC-IIB) and imma-
ture (MHC-emb, MHC-neo) isoforms (Fig. 5). In fact, the
time course of expression of MHC isoforms during the
recovery process was consistent with previous observations
(14): 1) the reexpression of immature isoforms between
D1 and D14 or D21 for MHC-emb and MHC-neo,
respectively; 2) the de novo expression of the fast isoforms
MHC-IIB and MHC-IIX until D28 and D35, respectively;
3) the MHC-IIA isoform, which is the only rapid isoform
expressed in adult SOL muscle of rats, peaked at D14
(P G 0.05 between regenerated and intact muscles), and then
decreased after D21 to return to basal values at D28; 4) the
relative amount of MHC-IA was recovered from day 28. Cr
supplementation had no effect on the MHC isoform
transitions observed during the regeneration process after
notexin-induced injury.
In this study, protein expression of MHC-IA was analyzed
by Western blot and reported to a determined amount of
proteins. There was a global effect of time of recovery
(P G 0.001) and injury (P G 0.001) on MHC-IA expression,
with a strong interaction between those factors (P G 0.001;
Fig. 6). MHC-IA protein levels were very low in regenerated
compared with intact muscles at D7 (P G 0.001) and then
progressively increased throughout the recovery time. MHC-
IA protein levels were similar in regenerated and intact
muscles of nontreated rats from D21. Although there was
no global effect of Cr supplementation, MHC-IA levels
remained low in regenerated muscles of Cr-treated rats at
D28 (P G 0.01). Interestingly, MHC-IA protein levels further
increased between D28 and D42 after injury (P G 0.05), with
higher levels in regenerated than in intact muscles both in
Cr-treated and nontreated rats (P G 0.05). In intact muscles,
MHC-IA protein expression was similar whatever the time of
observation, so that we have pooled the results of all intact
muscles of either nontreated or Cr-treated rats for graphical
representation (Fig. 6).
Enzyme activities. LDH activity was strongly affected
by both injury and time (global effects, P G 0.001) with a
strong interaction between these factors (Fig. 7A). Total
LDH activity strongly decreased at D1, and thereafter rapidly
increased (P G 0.05 between D7 and D3 and between D14
and D7), so that total LDH activity in regenerated muscles
represented only 73% of LDH activity measured in intact
muscles (P G 0.001). From D14 to D42, total LDH activity
slowly increased with levels at D42 similar to those in intact
muscles.
Considering specific activities of LDH, both H- and M-
LDH activities were markedly decreased at D1, but only M
isozyme of lactate dehydrogenase (M-LDH), which is the
glycolytic isoform of LDH, strongly recovered between D1
and D3 (P G 0.001) to reach similar levels as in intact
muscles as early as D3. On the contrary, the oxidative
isoform of LDH, namely H-LDH, only slightly and
progressively increased (P G 0.05) to reach lower levels than
that in intact muscles at D42 (74 T 5%, P G 0.001 and 85 T
8%, P G 0.05 for nontreated and Cr-treated rats, respectively;
Fig. 7A).
CS activity was markedly affected by injury and time of
recovery (global effect, P G 0.001, with interaction between
FIGURE 5—Distribution of MHC isoforms. MHC isoforms were
separated by SDS-PAGE and silver-stained. This technique enabled us
to separate both neonatal and embryonic MHC isoforms from the four
adult MHC. Data are expressed as a percentage of whole MHC in the
extract of SOL muscle.
FIGURE 6—Semiquantitative analysis of MHC-IA protein content by
Western blotting. After separation on polyacrylamide gels and
immunoblotting by antibody against MHC-IA, the relative MHC-IA
expression was determined by the ratio of sample band intensity/
internal control band intensity. Values are mean T SEM. *Different
from intact group. †Different from the previous time for the same
group.
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these factors; Fig. 7B). CS activity strongly decreased at D1,
and thereafter rapidly increased (P G 0.05 between D3 and
D7 and between D7 and D14), so that CS activity was
similar in regenerated and intact muscles 14 d after initial
injury.
There were no effects of Cr supplementation on the
recovery of total, specific LDH, or CS activities.
DISCUSSION
In support of previous results provided mostly through
in vitro experiments (23,35), the present study was designed
to test the hypothesis that Cr supplementation may have
beneficial effects on the recovery of adult muscle properties
after extensive muscle injury. The main results are the
following: 1) although injury induced an early and strong
decrease of TCr and PCr contents within regenerated mus-
cles, Cr supplementation ensured recovery of TCr and PCr
concentrations faster than that in control nontreated rats; 2)
whether animals were supplemented with Cr, the mass of
regenerated muscles remained still lower than that of intact
ones, even 42 d after injury; 3) the MHC profile of regen-
erated muscles was recovered 35 d after injury, both in Cr-
treated and nontreated rats; 4) a full recovery of CS activity
was observed from D14, whereas the specific H-LDH
activity remained lower in the regenerated than in the intact
muscles until 42 d, without any differences between Cr-
treated and nontreated animals. Taken together, the present
results show that Cr supplementation had no beneficial
effects on the time course of recovery of skeletal muscle
mass and phenotype after notexin-induced injury in rats.
To assess the effects of Cr on the time course of recovery
of adult muscle properties, we used a well-defined model of
muscle injury in rats, known to cause a rapid and extensive
myofiber necrosis sparing satellite cells, followed by a
complete and synchronous regenerative process (9,17). Using
this model of muscle injury, it was shown that the full
recovery of muscle mass is delayed beyond 42 d, a result that
underlines the critical need to develop means to accelerate
and improve the muscle regeneration process. With this
intent, we used a Cr supplementation protocol expected to
ensure Cr loading within muscles. The total amount of Cr
daily ingested in the present study was higher than 5 gIkgj1,
a dosage previously shown to increase free Cr (30%), PCr
(15%), and TCr (20%) levels in rat SOL muscle after 5 d of
Cr feeding (26). In the present experiment, we verified that
Cr supplementation successfully increased Cr content within
intact muscles (31 T 8%, 11 T 10%, and 19 T 8% for free Cr,
PCr, and TCr, respectively). More interestingly, although
notexin-induced muscle injury led to a strong decrease of
TCr and PCr contents, we observed a fast and full recovery
of TCr content within regenerated muscles only in Cr-treated
rats. Seven days after the initial injury, TCr and PCr contents
in regenerated muscles of Cr-treated rats indeed reached
physiological levels similar to those observed in intact mus-
cles of nontreated rats, whereas 35 d after injury, Cr contents
were not fully restored in nontreated rats. These findings
suggest a fast recovery of the sodium-dependent Cr trans-
porter, the major route of Cr entry into myofibers (8).
Once reexpressed in sarcolemma of regenerative myofibers,
the Cr uptake rate is expected to be enhanced by dietary
Cr supplementation, at least partly because intracellular
Cr concentration is low during the first steps of muscle
regeneration (7).
We failed to accelerate the recovery of adult muscle
phenotype by Cr supplementation, either for the fast recovery
of oxidative capacities, as estimated by the level of CS and H-
LDH activities, or recovery of the slow MHC profile. The
time course of MHC-IA expression and relative distribution
of MHC isoforms were similar in regenerated muscles from
Cr-treated and nontreated rats. These results might be
surprising considering that Cr supplementation has been
previously described to increase the expression of specific
FIGURE 7—Activities of total and specific H- and M-LDH (A) and of
CS (B). Total LDH activity was assessed by spectrophotometry. LDH
isoenzymes were separated by electrophoresis and the proportions of
the H and M isoenzymes bands were calculated according to the
following formulae: %H-LDL = %H4 + 0.75%H3M + 0.5%H2M2 +
0.25%HM3; %M-LDH = 0.25%H3M + 0.5%H2M2 + 0.75%HM3 +
%M4. The activities of H and M isoenzymes were calculated as the
product of total LDH activity to the percentage of each isoenzyme. All
LDH activities are expressed as the ratio of activity of regenerated
muscles to the activity of intact contralateral muscles. CS activity was
assessed at 30-C using acetyl-CoA and oxaloacetic acid as substrates.
CS activity is expressed in UI per gram of fresh weight of muscle
(UIIgj1 fw). Data are presented as mean T SEM. *Different from intact
group. †Different from the previous time for the same experimental
group.
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target genes, especially those encoding MHC isoforms
(11,20,30,36). However, recent evidences indicate that Cr
does not induce any direct anabolic effect on protein syn-
thesis (10,15,22,27) but most probably reduces the rate of
protein breakdown (27).
Although the Cr supplementation was efficient to increase
TCr and PCr contents in regenerated muscles, the recovery of
muscle mass has not improved in Cr-treated rats, whenever
the time after injury. The analysis of the mean fiber cross-
sectional area and the number of fibers per cross-section
revealed that this incomplete recovery of regenerated muscle
mass was clearly due to the atrophy of muscle fibers, which
appeared similar in Cr-treated and nontreated rats. By contrast,
the number of fibers per cross-section was strongly increased
in regenerated muscles in the same extent in Cr-treated and
nontreated rats, suggesting that the recruitment and the
proliferation of satellite cells were similar in both groups and
were not the limited step for the recovery of muscle mass.
Although it has been shown that Cr affects satellite
cell proliferation and differentiation in cell culture (35) and
that Cr-induced hypertrophy of C2C12 cells was, at least
partly, mediated by overexpression of IGF-1 and MRF
(23), the present results failed to show any positive effect
of Cr supplementation on the early step of muscle regen-
eration in rats. We used PCNA expression to examine the
cellular activity during the proliferating step (13,27). In our
conditions, PCNA expression could be relevant to cellular
events related to proliferation of satellite cells and/or
infiltrating nonmyogenic cells. Moreover, MyoD, which
augments during the proliferative step, is representative of
the myogenic differentiation (31). PCNA levels increased
from D1 to D14 and such an increase was only partially
associated with increased levels of MyoD, which likely
means that only a part of the proliferating cells has myogenic
capacities. In fact, the peak of PCNA observed at D3 was
more likely due to infiltrating inflammatory cells, as
highlighted by the histological aspect of regenerating
muscles (Fig. 2). Nevertheless, the time course of prolifer-
ation as assessed by PCNA expression was not affected by
Cr supplementation. In particular, there was no additional
wave of proliferating cells in regenerated muscles of Cr-
treated rats at D3. In a recent study, no effects of Cr on
PCNA and MyoD mRNA levels were observed after a
resistance exercise session consisting of mainly eccentric
muscle contractions in humans (11). Thus, a clear discrep-
ancy exists between in vitro and in vivo studies, possibly due
to larger changes in TCr and/or PCr cell content in vitro than
in vivo (12,23). The concentration of Cr in the medium of
cell culture studies (typically 5 mM) indeed leads to TCr
content within myotubes of approximately 700 mmolIkgj1
(12), which strongly exceeds the concentration of Cr within
muscles during the in vivo experiment.
Muscle regeneration after extensive muscle injury consists
on an initial mitotic phase, which provides new myonuclei
required to increase protein synthesis during the subsequent
phase of differentiation and maturation. In another model
that requires a strong increase in protein synthesis for muscle
hypertrophic adaptation, namely, the model of compensatory
overload by ablation of synergistic muscles, Young and
Young (37) also failed to find any effect of Cr supplemen-
tation on SOL muscle mass or performance. Many other
previous studies evidenced increased muscle mass and
strength in response to Cr supplementation, but mostly in
parallel with a physical training program (5). Hespel et al.
(18) reported that Cr improved muscle recovery in humans
during the rehabilitation phase after an immobilization
period of 2 wk. Muscle biopsies taken in those patients
showed changes in the MRF profile with Cr suggesting a
potential relationship with a faster muscle regrowth.
Recently, a higher level of satellite cell activation has been
observed in humans supplemented with Cr and submitted to
a training program of resistance exercises in comparison to
a group performing the same program but receiving a
placebo (25). These previous findings disagree by some
aspects with the present results. However, rats of the present
study were maintained at rest, and the combined effects of
contractile activity and Cr supplementation are questioned.
We previously showed that increasing physical activity
during muscle regeneration was able to ensure the early and
full recovery of muscle mass (28). Thus, it would be of
interest to test the hypothesis that providing Cr supplemen-
tation in exercising rats would be able to improve the
recovery of muscle mass after extensive injury because of
the conjunction of Cr loading and direct stimuli related to
physical exercise on protein synthesis. Further studies are
clearly necessary to test such hypothesis.
In conclusion, oral Cr supplementation was able to increase
TCr and PCr contents within both intact and regenerated
muscles of rats but was ineffective in accelerating the time
course of recovery of skeletal muscle mass and phenotype
after extensive injury.
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